My research and clinical work is focused on the treatment of Leukemia and Lymphoma, mostly in the form of targeted therapy, immunotherapy and cellular therapy. I have developed a particular interest in clinical and translational investigation and I have been a collaborator on several published and ongoing clinical trials.
I have been heavily involved in working on several projects related to immunotherapy and epigenetics with the NIH and IU. As PI or co-Investigator on several studies and protocols, I laid the groundwork for different trials, relevant to areas of unmet need. I have a great experience in establishing strong ties with community providers that will make it possible to recruit and track participants over time. In addition, I successfully administered projects (e.g. staffing, research protections, budget), collaborated with other researchers, and produced several peer-reviewed publications from each project.
Currently, much of my research is focused on understanding the mechanisms behind immunotherapy and how to optimize its efficacy, mostly for the treatment of leukemia, an area of great unmet needs. This includes the identification of new targets for immunotherapy and the development of new drugs to enhance the immune response. Another area of active interest is combining immunotherapy with other treatments, such as chemotherapy, to improve patient outcomes.
In terms of cellular therapy, I am interested in developing CAR-T cells for leukemia treatment while integrating new technologies and personalized medicine. I have prepared several proposals and submitted some for approval
Fellowship - UT MD Anderson Cancer Center, Houston, TX 2018
M.D. - American University of Beirut Medical Center, Beirut, Lebanon 2016
M.D. - Lebanese University, Faculty of Medical Sciences, Beruit, Lebanon 2010-2013